Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
AUTOR(ES)
Sutton, M. S.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=483628Documentos Relacionados
- How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
- Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P.
- The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians.
- Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors.
- Inhibition of the Angiotensin I Converting Enzyme (ACE) and proteolysis of non-fat probiotic yogurt